Data from Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation
Alessio Ugolini(The Wistar Institute), Filippo Veglia(Moffitt Cancer Center), Bárbara Peixoto(Moffitt Cancer Center), Paulo C. Rodrı́guez(Moffitt Cancer Center), Luca D’Angelo(Policlinico Umberto I), Alessandra De Leo(Moffitt Cancer Center), Antonio Santoro(Policlinico Umberto I), José R. Conejo-García(Duke University), Fabio Scirocchi(Bambino Gesù Children's Hospital), Marianna Nuti(National Institutes of Health), James K. Liu(Moffitt Cancer Center), Arnold B. Etame(Moffitt Cancer Center), Angelica Pace(Sapienza University of Rome), Aurelia Rughetti(Sapienza University of Rome), Xiaoqing Yu(Moffitt Cancer Center), Delia Scocozza(Moffitt Cancer Center), Xiaoxian Liu(Florida Museum of Natural History), Michela Perego(The Wistar Institute), Michael A. Vogelbaum(Moffitt Cancer Center), Alessandro Gardini(The Wistar Institute)
Cited by 0
Related Papers
Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses
|Cancer Research|2004|1.2k
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
|Cell|2015|921
A spectrum of monoclonal antibodies reactive with human mammary tumor cells.
|Proceedings of the National Academy of Sciences|1981|563
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540